KOO - If APB is as good as what the science suggests it is then that is exactly what Eversana signed on for. You have seen past estimates for sales for Cardio of 2 to 10 billion annually from the company and others(myself included). When you add in COVID and PAH that number gets even higher. With some luck we will add CKD, sclerosis and dementia and that number could get amazingly high. If we ever pass a trial without any hitches this ball will start rolling very fast and $500 million to $1 billion will come and go before you know it, so yes indeed in our lifetime if if if.

tada